课题基金 / 基金详情

Validation of the innovative clinical endpoint capture methods in the pragmatic multi-center randomized trial "Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long- term Effectiveness (ADAPTABLE)"

Validation of the innovative clinical endpoint capture methods in the pragmatic multi-center randomized trial "Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long- term Effectiveness (ADAPTABLE)"
在务实的多中心随机试验“阿司匹林剂量：以患者为中心的试验评估益处和长期有效性（ADAPTABLE）”中验证创新的临床终点捕获方法
批准号：
376317
负责人：
Marquis-Gravel Guillaume
金额：
$8.74万
依托单位：
Duke Clinical Research Institute (NC)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-11-01 至 2019-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=376317&lang=en
关键词：
Aspirin Atherosclerotic Cardiovascular Diseases Cardiology Patient-Oriented Outcomes Pragmatic Trial Randomized Controlled Trial Secondary Prevention

项目摘要

项目成果

Marquis-Gravel Guillaume的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Clinical trials of good quality are necessary to assess the efficacy and safety of new medical treatments. However, long-term follow-up of patients treated with novel therapies is often complex and expensive, hindering the implementation of high-scale res
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ImproviNg rEnal outcomes following coronary angiograPhy and/or percuTaneoUs coroNary intErventions: a pragmatic, adaptive, patient-oriented randomized controlled trial
  • 批准号：
    478732
  • 项目类别：
    Operating Grants
  • 资助金额：
    $69.66万
  • 财政年份：
    2023
  • 负责人：
    Marquis-Gravel Guillaume
  • 依托单位：
    Montreal Heart Institute
海外基金